2014, Number 2
PDF size: 130.78 Kb.
ABSTRACTThe metastatic non-small-cell lung cancer patients have a poor prognosis. Present debates discuss a group of these patients with synchronous or metachronous lesions that can survive for a long period of time after removing the primary lesion, and its metastases of cerebral and adrenal location in vast majority. In this regard, an extensive literature review focused on the metastatic condition of the non small cell lung cancer was made. Databases such as Pubmed, Medline, Ebsco, Cochrane and Redalyc were consulted and scientific evidence on this topic was analyzed. It was concluded that metastases and recurrences found in patients suffering pulmonary cancer have been considered as conditions pointing to death. These patients have been treated with systemic therapies as a group. The surgery remains a therapeutic option, reinforcing the theory of “the seed and the soil"
García Rodríguez ME, Armas Pérez BA, Armas Moredo K. Actualización en el tratamiento del cáncer pulmonar de células no pequeñas en etapa IIIA con afectación N2. Rev Cubana Cir [revista en la Internet]. 2012 Sep [citado 2013 Jun 03];51(3):217-33. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S003474932012000300003&lng=es
Maeda R, Yoshida J, Ishii G, Hishida T, Nishimura M, Nagai K. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. Chest. 2011;140(6):1494-502.